HomeIPSC • NASDAQ
add
Century Therapeutics Inc
Previous close
$2.34
Day range
$2.32 - $2.47
Year range
$0.34 - $3.03
Market cap
435.83M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.88M | -26.56% |
Net income | -19.17M | 46.85% |
Net profit margin | — | — |
Earnings per share | -0.25 | 29.42% |
EBITDA | -22.02M | 26.32% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.11M | -38.13% |
Total assets | 223.70M | -36.67% |
Total liabilities | 64.77M | -66.24% |
Total equity | 158.94M | — |
Shares outstanding | 179.72M | — |
Price to book | 1.29 | — |
Return on assets | -27.29% | — |
Return on capital | -30.17% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.17M | 46.85% |
Cash from operations | -16.08M | 33.63% |
Cash from investing | 22.36M | -26.94% |
Cash from financing | 53.00K | 108.80% |
Net change in cash | 6.34M | 9.62% |
Free cash flow | -11.04M | -111.37% |
About
Founded
2018
Headquarters
Website
Employees
78
